TD Ameritrade Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-86
Closed -$5K 408
2023
Q2
$5K Sell
86
-32
-27% -$1.72K ﹤0.01% 408
2023
Q1
$6K Sell
118
-101
-46% -$4.91K ﹤0.01% 418
2022
Q4
$11K Sell
219
-142
-39% -$6.23K ﹤0.01% 380
2022
Q3
$14K Sell
361
-59
-14% -$2.63K ﹤0.01% 359
2022
Q2
$21K Sell
420
-329
-44% -$17.5K ﹤0.01% 378
2022
Q1
$38K Sell
749
-87
-10% -$4.49K ﹤0.01% 379
2021
Q4
$42K Buy
836
+195
+30% +$9.64K ﹤0.01% 368
2021
Q3
$32K Sell
641
-255
-28% -$13K ﹤0.01% 360
2021
Q2
$47K Sell
896
-111
-11% -$5.79K ﹤0.01% 346
2021
Q1
$49K Hold
1,007
﹤0.01% 337
2020
Q4
$49K Buy
1,007
+366
+57% +$18.1K ﹤0.01% 337
2020
Q3
$32K Buy
641
+284
+80% +$14.6K ﹤0.01% 360
2020
Q2
$18K Buy
357
+291
+441% +$14.1K ﹤0.01% 385
2020
Q1
$3K Sell
66
-38
-37% -$1.82K ﹤0.01% 526
2019
Q4
$5K Buy
+104
New +$4.87K ﹤0.01% 518

Other funds holding SNY

TD Ameritrade Investment Management's SNY Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Sanofi (SNY) in Q3 2023, closing a stake of 86 shares — an estimated $5K sold.

TD Ameritrade Investment Management first reported a position in SNY in Q4 2019 and held it in 15 quarters. The position peaked at $49K in Q1 2021. 697 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 86 Sanofi shares in Q3 2023, an estimated $5K.
  • TD Ameritrade Investment Management first reported a position in Sanofi in Q4 2019 and held it in 15 quarters.
  • TD Ameritrade Investment Management's Sanofi position peaked at $49K in Q1 2021.
  • 697 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.